Lyell Immunopharma, Inc. (LYEL) Total assets 2020–2025
Lyell Immunopharma, Inc. (LYEL) total assets at each fiscal year-end, per SEC filings.
$340.1MFY2025 · since FY2020: $908.3M → $340.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $340.1M | -30.7% |
| FY2024 | $490.9M | -34.6% |
| FY2023 | $750.0M | -20.0% |
| FY2022 | $937.6M | -16.8% |
| FY2021 | $1.1B | +24.1% |
| FY2020 | $908.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LYEL financial trends
LYEL RevenueLYEL Net incomeLYEL Net marginLYEL Gross profitLYEL Gross marginLYEL Operating incomeLYEL Operating marginLYEL Operating cash flowLYEL Free cash flowLYEL Capital expendituresLYEL Return on equityLYEL Stock buybacksLYEL Dividends paidLYEL Total liabilitiesLYEL Shareholders’ equityLYEL overview →